Citadel Embolization Device Study
B
Bradley N. Bohnstedt, MD
Primary Investigator
Overview
The purpose of this study is to gather preliminary safety and effectiveness data on Citadelbolization Device in the treatment of wide-neck intracranial aneurysms.
Description
In this study, use of the Citadel Embolization Device will be limited to a population ofwith unruptured or ruptured wide-neck aneurysms who meet all study eligibility. The Citadel Embolization Device is intended to endovascularly obstruct or occlude
blood flow in intracranial aneurysms.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Unruptured Wide-neck Aneurysms
-
Age: Between 18 Years - 80 Years
-
Gender: All
Inclusion Criteria:
- Has a single, unruptured or ruptured target intracranial aneurysm that is suitable fordovascular treatment.
Exclusion Criteria:
1.Target aneurysm has been previously treated
Updated on
29 Apr 2024.
Study ID: CDM10001448
Please visit our main page to search for other studies you may be interested in.
If you need help finding a study or have any questions, please contact us at inhealth@iu.edu
